Key result
Single strand conformation polymorphism screening identified five different pathogenic mutations in 6 of 192 (3.1%) DMD/BMD patients without detectable deletions.
Observational (n=192)
The study identifies novel small pathogenic mutations in the dystrophin gene in a subset of DMD/BMD patients without large deletions, expanding the known mutation spectrum.
May inform expanded genetic testing in DMD/BMD; hypothesis-generating pending larger studies.
Duchenne (DMD) and Becker (BMD) type muscular dystrophies are allelic X-linked recessive disorders caused by mutations in the gene encoding dystrophin. About 65% of the cases are caused by deletions, while 5-10% are duplications. The remaining 30% of affected individuals may have smaller mutations (point mutations or small deletions/insertions) which cannot be identified by current diagnostic screening strategies. In order to look for pathogenic small mutations in the dystrophin gene, we have screened the 18 exons located in the hot spot region of this gene through two different single strand conformation polymorphism (SSCP) conditions. Five different pathogenic mutations were identified in 6 out of 192 DMD/BMD patients without detectable deletions: 2 nonsense, 1 bp insertion, 1 bp deletion and 1 intronic. Except for the intronic change, which alters a splice site, all the others cause a premature stop codon. In addition, 8 apparently neutral changes were identified. However, interestingly, one of them was not identified in 195 normal chromosomes, although it was previously described in a DMD patient from a different population. The possibility that this mutation may be pathogenic is discussed. Except for two neutral changes, all the others are apparently here described for the first time.
No takes yet. Share an insight, caveat, or question.
Sitnik et al. (1997) conducted an observational in Duchenne (DMD) and Becker (BMD) type muscular dystrophies (n=192). Single strand conformation polymorphism (SSCP) screening was evaluated on Identification of pathogenic small mutations. Single strand conformation polymorphism screening identified five different pathogenic mutations in 6 of 192 (3.1%) DMD/BMD patients without detectable deletions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: